A new study has been published in Vaccines that evaluated the effectiveness of Cominarty against documented SARS-CoV-2 infection and symptomatic diseases in the medium to long term.
Real-world data from Pasquale Stefanizzi of Aldo Moro University in Italy and colleagues confirm that the Pfizer-BioNTech vaccine effectively prevents COVID-19 infection.